A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with FGFR3 alterations: Initial results from FORAGER-1.
KUALA LUMPUR: A 27-year-old man died when he was run over by a Light Rail Transit (LRT) train after he fell onto the track at the Dato' Keramat LRT station on Friday (Dec 1) night. According to ...